News & Updates
Filter by Specialty:

COVID-19 vaccines weaker in liver transplant recipients, CLD patients
19 Nov 2021
byTristan Manalac
Vaccines against the coronavirus disease 2019 (COVID-19) induce weaker and more transient immune responses in liver transplant recipients, those with cirrhosis, or those with chronic liver disease (CLD), according to a study presented at The Liver Meeting Digital Experience 2021 by the American Association for the Study of Liver Diseases (AASLD 2021).
COVID-19 vaccines weaker in liver transplant recipients, CLD patients
19 Nov 2021
No trade-off between bleeding and ischaemic risk with abbreviated DAPT
19 Nov 2021
byElvira Manzano
Stopping dual antiplatelet therapy (DAPT) after 1 month appeared safe in high-bleeding risk (HBR) patients with acute myocardial infarction (MI) who were implanted with a newer coronary stent, a prespecified subanalysis of the MASTER DAPT* trial has shown.